InvestSMART

Algorae Pharmaceuticals Limited (ASX: 1AI) - Announcements

Current share price for 1AI : $0.013 0.001 (8.33%)+

ASX company news and announcements for Algorae Pharmaceuticals Limited (1AI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Algorae Pharmaceuticals Limited (1AI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Algorae Pharmaceuticals Limited (1AI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Algorae Pharmaceuticals Limited (1AI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Application for quotation of securities - 1AI 7 Nov 2025 4:22PM $0.009 $0.013 risen by 44.44%
$26 Quarterly Activities Report /Appendix 4C Cash Flow Statement 28 Oct 2025 9:00AM $0.010 $0.013 risen by 30%
$26 Algorae Signs Binding Term Sheet with Cadila Pharmaceuticals 20 Oct 2025 8:59AM $0.011 $0.013 risen by 18.18%
$26 Algorae Appoints Chief Operating Officer, Mr David Gulland 16 Oct 2025 9:03AM $0.010 $0.013 risen by 30%
$26 Appendix 3Y x3 3 Oct 2025 4:48PM $0.010 $0.013 risen by 36.84%
$26 Notification regarding unquoted securities - 1AI 3 Oct 2025 4:41PM $0.010 $0.013 risen by 36.84%
$26 Proposed issue of securities - 1AI 2 Oct 2025 11:51AM $0.008 $0.013 risen by 62.50%
$26 Updated Securities Trading Policy 2 Oct 2025 11:47AM $0.008 $0.013 risen by 62.50%
$26 Adoption of Updated Constitution 2 Oct 2025 11:43AM $0.008 $0.013 risen by 62.50%
$26 Results of Meeting 2 Oct 2025 11:31AM $0.008 $0.013 risen by 62.50%
$26 AGM Chairman Address to Shareholders 2 Oct 2025 10:00AM $0.009 $0.013 risen by 52.94%
$26 Algorae Signs Exclusive License Agreement with Sakar 23 Sep 2025 8:53AM $0.008 $0.013 risen by 62.50%
$26 Notice of Annual General Meeting/Proxy Form 2 Sep 2025 4:37PM $0.009 $0.013 risen by 44.44%
$26 Appendix 4G and Corporate Governance Statement 28 Aug 2025 5:31PM $0.009 $0.013 risen by 44.44%
$26 Annual Report and Appendix 4E 28 Aug 2025 5:20PM $0.009 $0.013 risen by 44.44%
$26 Date of AGM and Closing Date for Director Nominations 13 Aug 2025 6:03PM $0.006 $0.013 risen by 116.67%
$26 Quarterly Activities Report /Appendix 4C Cash Flow Statement 29 Jul 2025 8:40AM $0.006 $0.013 risen by 116.67%
$26 Notification regarding unquoted securities - 1AI 28 Jul 2025 4:10PM $0.006 $0.013 risen by 116.67%
$26 Proposed issue of securities - 1AI 25 Jul 2025 4:58PM $0.006 $0.013 risen by 116.67%
$26 Algorae Receives A$318,771 R&D Cash Rebate from ATO 6 Jun 2025 8:49AM $0.005 $0.013 risen by 160%
$26 Peter Mac Partners with Algorae on AI Drug Targets 8 May 2025 9:01AM $0.007 $0.013 risen by 85.71%
$26 Quarterly Activities Report /Appendix 4C Cash Flow Statement 29 Apr 2025 8:44AM $0.006 $0.013 risen by 116.67%
$26 Algorae Appoints Chief Commercial Officer, Mr Vishal Shah 3 Apr 2025 9:03AM $0.006 $0.013 risen by 136.36%
$26 Algorae Receives A$451,359 R&D Cash Rebate from ATO 31 Mar 2025 8:58AM $0.005 $0.013 risen by 160%
$26 Cleansing Notice 7 Mar 2025 6:52PM $0.005 $0.013 risen by 160%

76 - 100 of 186 results

Page 4 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.